Tactile Systems Technology Inc. (3L3)

Overview

Tactile Systems Technology, Inc. is a pioneering medical technology entity focused on designing, developing, and marketing innovative medical devices tailored to treat chronic diseases that are often neglected by the current healthcare model, predominantly in the United States. Founded in 1995 and strategically headquartered in Minneapolis, Minnesota, the company has carved a niche for itself by offering cutting-edge solutions that aim to improve the quality of life for patients suffering from conditions such as lymphedema, chronic venous insufficiency, and respiratory diseases. Through its commitment to advancing medical care at home, Tactile Systems Technology stands at the forefront of facilitating accessible and effective treatment options beyond the confines of traditional hospital settings.

Products and Services

• Flexitouch Plus system

  A revolutionary pneumatic compression device, the Flexitouch Plus is designed to provide comprehensive treatment for lymphedema within the comfort of the patient's home. This system utilizes advanced technology to simulate manual lymphatic drainage therapy, which helps reduce swelling and manage symptoms effectively, providing relief to those suffering from this often debilitating condition.

• Entre Plus System

  Understanding the challenges faced by individuals with venous disorders, Tactile Systems Technology introduced the Entre Plus System, a portable pneumatic compression device that caters to the at-home treatment of conditions such as lymphedema and chronic venous insufficiency, including the painful and hard-to-heal venous leg ulcers. This device offers a practical solution for patients to manage their conditions effectively from the comfort of their homes, enhancing their quality of life.

• Kylee mobile application

  With the digital age revolutionizing healthcare management, Tactile Systems Technology developed Kylee, a user-friendly mobile application aimed at empowering patients to better understand lymphedema, monitor their symptoms and treatment progress, and seamlessly share this data with their healthcare providers. This innovative app fosters patient engagement and encourages active participation in their healthcare journey, promoting better outcomes.

• AffloVest

  The AffloVest represents a significant advancement in respiratory care, offering a portable high frequency chest wall oscillation vest designed to aid patients struggling with retained pulmonary secretions due to conditions like bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Its portability ensures patients can receive consistent treatment, regardless of their location, making it a vital tool in managing respiratory conditions more effectively.